Comparison of a Whole-Brain Contrast-Enhanced 3D TSE T1WI versus Orbits Contrast-Enhanced 2D Coronal T1WI at 3T MRI for the Detection of Optic Nerve Enhancement in Patients with Acute Loss of Visual Acuity.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
20 Jun 2024
Historique:
received: 19 03 2023
accepted: 07 02 2024
medline: 21 6 2024
pubmed: 21 6 2024
entrez: 20 6 2024
Statut: aheadofprint

Résumé

MR imaging is the technique of choice for patients presenting with acute loss of visual acuity with no obvious ophthalmologic cause. The goal of our study was to compare orbits contrast-enhanced 2D coronal T1WI with a whole-brain contrast-enhanced 3D (WBCE-3D) TSE T1WI at 3T for the detection of optic nerve enhancement. This institutional review board-approved retrospective single-center study included patients presenting with acute loss of vision who underwent 3T MR imaging from November 2014 to February 2020. Two radiologists, blinded to all data, individually assessed the presence of enhancement of the optic nerve on orbits contrast-enhanced 2D T1WI and WBCE-3D T1WI separately and in random order. A McNemar test and a Cohen κ method were used for comparing the 2 MR imaging sequences. One thousand twenty-three patients (638 women and 385 men; mean age, 42 [SD, 18.3] years) were included. There was a strong concordance between WBCE-3D T1WI and orbits contrast-enhanced 2D T1WI when detecting enhancement of the optic nerve: κ = 0.87 (95% CI, 0.84-0.90). WBCE-3D T1WI was significantly more likely to detect canalicular enhancement compared with orbits contrast-enhanced 2D T1WI: 178/1023 (17.4%) versus 138/1023 (13.5%) ( Our study showed that there was a strong concordance between WBCE-3D T1WI and orbits contrast-enhanced 2D T1WI when detecting enhancement of the optic nerve in patients with acute loss of visual acuity with no obvious ophthalmologic cause. WBCE-3D T1WI demonstrated higher sensitivity and specificity in diagnosing optic neuritis, particularly in cases involving the canalicular segments.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
MR imaging is the technique of choice for patients presenting with acute loss of visual acuity with no obvious ophthalmologic cause. The goal of our study was to compare orbits contrast-enhanced 2D coronal T1WI with a whole-brain contrast-enhanced 3D (WBCE-3D) TSE T1WI at 3T for the detection of optic nerve enhancement.
MATERIALS AND METHODS METHODS
This institutional review board-approved retrospective single-center study included patients presenting with acute loss of vision who underwent 3T MR imaging from November 2014 to February 2020. Two radiologists, blinded to all data, individually assessed the presence of enhancement of the optic nerve on orbits contrast-enhanced 2D T1WI and WBCE-3D T1WI separately and in random order. A McNemar test and a Cohen κ method were used for comparing the 2 MR imaging sequences.
RESULTS RESULTS
One thousand twenty-three patients (638 women and 385 men; mean age, 42 [SD, 18.3] years) were included. There was a strong concordance between WBCE-3D T1WI and orbits contrast-enhanced 2D T1WI when detecting enhancement of the optic nerve: κ = 0.87 (95% CI, 0.84-0.90). WBCE-3D T1WI was significantly more likely to detect canalicular enhancement compared with orbits contrast-enhanced 2D T1WI: 178/1023 (17.4%) versus 138/1023 (13.5%) (
CONCLUSIONS CONCLUSIONS
Our study showed that there was a strong concordance between WBCE-3D T1WI and orbits contrast-enhanced 2D T1WI when detecting enhancement of the optic nerve in patients with acute loss of visual acuity with no obvious ophthalmologic cause. WBCE-3D T1WI demonstrated higher sensitivity and specificity in diagnosing optic neuritis, particularly in cases involving the canalicular segments.

Identifiants

pubmed: 38902008
pii: ajnr.A8233
doi: 10.3174/ajnr.A8233
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by American Journal of Neuroradiology.

Auteurs

David Prillard (D)

From the Department of Neuroradiology (D.P., F.C., P.C., J.S., A.L.), A. Rothschild Foundation Hospital, Paris, France alecler@for.paris.

Frédérique Charbonneau (F)

From the Department of Neuroradiology (D.P., F.C., P.C., J.S., A.L.), A. Rothschild Foundation Hospital, Paris, France.

Pierre Clavel (P)

From the Department of Neuroradiology (D.P., F.C., P.C., J.S., A.L.), A. Rothschild Foundation Hospital, Paris, France.

Catherine Vignal-Clermont (C)

Department of Ophthalmology (C.V.-C.), A. Rothschild Foundation Hospital, Paris, France.

Romain Deschamps (R)

Department of Neurology (R.D., M.B.d.l.M.), A. Rothschild Foundation Hospital, Paris, France.

Marine Boudot de la Motte (MB)

Department of Neurology (R.D., M.B.d.l.M.), A. Rothschild Foundation Hospital, Paris, France.

Jessica Guillaume (J)

Department of Clinical Research (J.G.), A. Rothschild Foundation Hospital, Paris, France.

Julien Savatovsky (J)

From the Department of Neuroradiology (D.P., F.C., P.C., J.S., A.L.), A. Rothschild Foundation Hospital, Paris, France.

Augustin Lecler (A)

From the Department of Neuroradiology (D.P., F.C., P.C., J.S., A.L.), A. Rothschild Foundation Hospital, Paris, France.

Classifications MeSH